May's top stories: Funders and NGOs agreed on new standards, Actinogen's Xanamem in Phase II

Image: DPX-Survivac to enter Phase II trial for DLBCL. Photo: courtesy of David Castillo Dominici/FreeDigitalPhotos.net.